Characteristics of oestrus measured using visual observation and radiotelemetry

The aim of this study was to measure the level of agreement between characteristics of oestrus measured using visual observation and radiotelemetry. Oestrous cycles in 20 non-lactating Holstein cows were synchronised by treatment with an intravaginal progesterone releasing inserts and injections of oestradiol benzoate for a first oestrus (Round 1) and then re-synchronised for two subsequent and successive oestrous cycles (Rounds 2 and 3). Cows were ovariectomised following the third synchronised oestrus and then retreated to induce oestrus (Round 4). Oestrus was monitored by continuous visual observation and radiotelemetry between 24 and at least 60 h after removal of inserts at Rounds 1-4. Significant differences (P<0.001) were obtained between the mean number of mounts (42.7 versus 17.8), duration of oestrus (14.4h versus 10.9h), total duration of mounts (223.9s versus 33.1s), mean duration per mount (5.6s versus 1.9s), the number of mounts per hour (3.5 versus 2.0) and the interval to oestrus (41.2h versus 42.8h) between values determined by visual observation compared with radiotelemetry, respectively. The 95% limits of agreement for all the characteristics of oestrus measured were wide although the efficiency of detection of oestrus for both methods of recording oestrus were high (97.5% (78/80) versus 93.8% (75/80), for visual observation and radiotelemetry, respectively; P=0.25). We conclude that there is poor agreement between characteristics of oestrus measured with visual observation and radiotelemetry in Holstein cows following monitoring of synchronised oestrous cycles, although both methods were equally efficient for the detection of oestrus.     

Associations between the manipulation of patterns of follicular development and fertility in cattle

The wave-like patterns of ovarian follicular development in cattle can be manipulated by shortening the luteal phase with prostaglandin F2alpha (PGF), lengthening the period of follicle dominance with progesterone or curtailing follicle development with GnRH or oestradiol as 17beta, benzoate or cypionate. These hormones can also be used to synchronise ovulation allowing timed inseminations without detected oestrus. Progesterone, PGF, GnRH and oestradiol benzoate have each been used to increase conception rates in some situations, but their use has reduced them in others. For example, inseminations made within 96 h of a single injection of PGF administered during the luteal phase were associated with increased conception rates in dairy cows whereas double injection protocols reduced conception rates. The three forms of oestradiol and GnRH have greater effects on follicular development following divergence and dominance than following wave emergence. This can mean that follicles of differing maturity will be present about 7 days later and can result in varied intervals to the onset of oestrus following a PGF injection. The consequent variation in ovulation time can be reduced by injecting GnRH or an oestradiol during pro-oestrus. This means that some less mature follicles will ovulate, forming corpus luteum (CL) associated with a slower rise in plasma progesterone and lower mid-luteal concentrations. The lower conception rates recorded with single timed inseminations with synchronised ovulations have been associated with increased prevalences of short cycles in lactating dairy cows (with GnRH), with long luteal phases in cows and heifers (with oestradiol benzoate) and with embryo loss following positive pregnancy diagnosis (as with Ovsynch in lactating Holstein cows). Extensive Canadian studies have demonstrated that these same hormones can be successfully used without these limitations and reliably obtaining conception rates over 50% and up to 70% in beef cattle that have been supplemented with a progestin during the period of ovarian follicle synchronisation. The inherently lower fertility of Holstein cows during early lactation may be contributing to the reduced effectiveness of hormonal treatments for synchronised follicle development and ovulation. The role of reduced dose rates of GnRH in compromising this effectiveness needs to be determined if the potential of these treatments realised with beef cattle is to be achieved with lactating Holstein cows.     

Absorbable deslorelin implants (Ovuplant) prolong postpartum anestrus in early ovulating dairy cows

Two experiments were conducted to investigate the use of a bioabsorbable implant of the GnRH agonist deslorelin to temporarily delay the resumption of postpartum ovulatory cycles in Holstein cows. In Experiment 1, recently calved cows were paired and received either a single implant (Ovuplant); Peptech Animal Health, Sydney, NSW, Australia) within 48 h of parturition (OVP; n=17), or remained as untreated controls (CON; n=17). Blood samples were collected for plasma progesterone assay three times weekly for 6 weeks to profile the pattern of resumption of ovulatory cycles. In Experiment 2, there were 15 CON and 15 OVP cows initially treated as for Experiment 1 as well as 15 OVP+SYNCH cows. Each cow in the CON and OVP+SYNCH groups received a progesterone vaginal insert (CIDR); Genetics Australia, Bacchus Marsh, Vic., Australia) for 7 days at 23 days postpartum (23 dpp) to synchronise estrus in cycling animals or to induce an ovulation with estrus in anestrus animals. Blood samples were collected weekly until removal of the CIDR insert, and then twice weekly until 56 dpp to monitor plasma P4 for retrospective determination of ovulation. Milk yield was monitored by twice daily electronic volume measurements and milk composition with once weekly milk composition analysis.In Experiment 1, CON cows began ovulating from 9 dpp; 15 of 17 had ovulated by the end of blood sampling at 42 dpp. None of the OVP cows ovulated until at least 24 dpp, and only 6 of 17 had ovulated by 42 dpp. The average day of first ovulation was extended from 22.4+/-2.7 dpp to 39.3+/-2.7 dpp (P<0.05). In Experiment 2, ovulation had occurred in 8 of 15 CON cows at the time of CIDR insertion (23 dpp), 0 of 15 OVP cows and 1 of 15 OVP+SYNCH cows. By 40 dpp (or 10 days following removal of the CIDR insert) every CON cow (15/15) had ovulated, but only 2 of 15 OVP+SYNCH cows and 1 of 15 OVP cows. None of these effects of treatment was associated with any changes in milk yield or composition in either experiment.In conclusion, inserting a bioabsorbable implant of deslorelin within 48 postpartum extended the interval to first ovulation to at least 24 dpp in 46 of 47 cows. Recovery periods were highly variable. This variability was not reduced by using a form of intravaginal progesterone supplementation that did produce a synchronised estrus with ovulation in anestrus animals that had not been treated with deslorelin.     

Effects of level of feeding and progesterone dose on plasma and faecal progesterone in ovariectomised cows

The effects of two levels of feeding and two doses of progesterone (P4) on plasma and faecal progesterone metabolites (FP4M) were studied using a total of 24 ovariectomised (OVX), non-lactating, Holstein-Friesian cows. Cows were grazed on improved ryegrass/white clover pastures and allowed ad libitum access to pasture or were restricted to grazing for a total of 4 h per day in two 2 h periods. Progesterone (P4) was administered as one or two, simultaneous, intravaginal progesterone devices (CIDR). The cows were adapted to their pasture supply for 2 weeks before the start of the progesterone treatments. The progesterone devices were administered for 11 days and the cows were dosed with slow release chromic oxide capsules during the P4 treatment to allow faecal output (FO) to be estimated. Daily blood samples for P4 assay and weekly samples for blood metabolite assay were collected. Faecal samples were collected per rectum daily and assayed for pregnanes containing a 20-oxo-, 20alpha- or a 20beta-OH group by enzyme immunoassay (EIA). Daily FO was higher (P < 0.001) for ad libitum than pasture restricted cows (6.3 vs 4.1 kg DM) but was similar for both doses of P4. The average mass of P4 released from a CIDR device over a 11-day period was higher for cows allowed ad libitum pasture compared with those on restricted pasture (0.64 vs 0.60 g; P = 0.04). Plasma P4 concentrations, however, were higher in restricted than ad libitum fed cows (1x CIDR: 1.81 vs 1.41 ng/ml; 2x CIDR: 4.10 vs 3.46 ng/ml). Increasing the progesterone dose significantly (P < 0.001) increased both the concentrations and daily totals of the faecal pregnanes assayed and total FP4M. Restricted pasture cows had higher (P < 0.001) pregnanes and FP4M concentrations than cows fed ad libitum. Daily total faecal pregnane and FP4M did not differ between feeding levels except for faecal 20alpha-pregnane which was highest for ad libitum fed cows (P < 0.05). These results showed that the plasma concentrations of P4 in CIDR-treated OVX cows were negatively associated with the level of feeding. Level of feeding and dose of P4 affected the concentrations of FP4M, but the daily excretion rate of FP4M was not positively influenced by the level of feeding.     

Hormonal and ovarian responses to a 5-day progesterone treatment in anoestrous dairy cows in the third week post-partum

Primiparous cows with low body condition at calving have an extended anovulatory period. Induction of ovulation and oestrus is possible with progesterone treatment but the response to this treatment differs between Friesian and Jersey breeds. The objective of this study was to describe changes in pulsatile LH secretion and the synchrony of developing ovarian follicles that occur during a progesterone treatment period of 5 days in primiparous anovulatory cows. The experimental model compared the progesterone treatment with spontaneous post-partum changes as well as a breed comparison in a factorial design.Thirty-six cows (Jersey n=19 and Friesian n=17) were managed to calve with a low body condition score (BCS<4. 5). Daily changes in ovarian follicle size were observed with transrectal ultrasonography in each cow from 8 days post-partum. Thirty of these cows were diagnosed to be anovulatory at 12-18 days post-partum (day 0) and allocated to a treatment (n=16) or a control group (n=14), balanced for breed. Each treated cow had a progesterone-releasing controlled internal drug-releasing (CIDR) device inserted vaginally for 5 days while control cows were left untreated. Changes in plasma LH concentrations were measured with intensive blood sampling over 8 h on days -1, 1, and 4. Blood samples were also collected daily (06:00 h) for determination of plasma progesterone as well as oestradiol concentrations on days 6 and 8.Treatment with progesterone was associated with a transient initial decrease (day 1) in both LH pulse frequency and mean LH concentrations after device insertion, but both had returned to pre-treatment levels by day 4. Jersey cows had a greater pulse frequency, but there was no breed difference in mean LH concentrations. Patterns of ovarian follicle growth were affected by progesterone treatment with an increase in diameter of the dominant follicle (DF) identified after treatment initiation. This followed an earlier emergence of a new DF after device insertion. Follicular response to progesterone was dependent on the diameter of the DF present at treatment initiation. Those follicles >/=9 mm were replaced by a new DF during treatment such that the DF observed at the time of device removal was large (>/=9 mm) and growing in 13/16 cases.Progesterone was not effective for the induction of an LH surge, ovulation and oestrus in anovulatory cows with a low BCS. However, treatment was associated with synchronous development of a DF so that it was large and growing at the end of the treatment period in most cases. This synchronous development may be due to the transient suppression of LH and the presence of an LH-dependent DF.     

Hormones of young tassels of Zea mays

The ethyl acetate-soluble acids from an aqueous methanolic extract of young tassels from Zea mays plants were fractionated by treatment with PVP, then by chromatography on a column of celite-charcoal. Methylated and trimethylsilylated fractions were analysed by GC/MS and the following compounds were identified by comparison with reference spectra: GA₁₇, GA₁₉, GA₂₀, GA₄₄, GA₅₃, ABA, phaseic acid and dihydrophaseic acid. Evidence is also presented for the presence of metabolise C of ABA and of a 16,17-dihydro-17-hydroxy-derivative of GA₅₃. In addition, the presence of small amounts of GA₁, GA₈ and GA₂₉, was indicated from a derivatized fraction analysed by capillary GC/SICM.     

Analysis of the Anaplasma marginale major surface protein 1 complex protein composition by tandem mass spectrometry

The protective major surface protein 1 (MSP1) complex of Anaplasma marginale is a heteromer of MSP1a and MSP1b, encoded by a multigene family. The msp1beta sequences were highly conserved throughout infection. However, liquid chromatography-tandem mass spectrometry analysis identified only a single MSP1b protein, MSP1b1, within the MSP1 complex.     

Ovarian follicular development and hormone concentrations in inseminated dairy cows with resynchronized estrous cycles

The objective was to investigate ovarian follicular development and hormone concentrations in previously inseminated cows with estrous cycles resynchronized with various resynchronization treatments. Lactating dairy cows were treated with a previously used intravaginal progesterone releasing device (IVD) for 7d (EB+IVD 7+EB, n=15) or 8d (EB+IVD 8+EB, n=16), starting 13d (Day 13) after a first estrus (Day 0) and AI. Estradiol benzoate (EB; 1mgim) was given at device insertion and 24h after removal. Other cows were given the same treatment as the EB+IVD 8+EB cows, but were not treated with EB at IVD insertion (IVD 8+EB, n=11). There were no differences (P>0.05) between EB+IVD 7+EB and EB+IVD 8+EB treatments for follicle dynamics and plasma progesterone concentrations during treatment. Based on a comparison between the IVD 8+EB treated cows and the pooled results of the EB+IVD 7+EB and EB+IVD 8+EB treated cows, EB at device insertion increased the number of follicular waves between Days 13 and 20 (mean+/-S.E.M.; 2.3+/-0.14 vs 2.7+/-0.10, P=0.033), delayed emergence of follicles that were dominant or emerging on Day 20 (17.2+/-0.36 vs 14.1+/-0.65d, P<0.001), reduced diameters of dominant or emerging follicles on Day 20 (9.0+/-0.58 vs 12.7+/-0.59, P<0.001), and reduced plasma progesterone concentrations by 0.85+/-0.44ng/mL (P=0.059) during treatment. Furthermore, comparison of the IVD 8+EB to the EB+IVD 8+EB treated cows demonstrated that treatment with EB at device insertion also reduced the diameter of ovulatory follicles (14.2+/-0.58 vs 19.0+/-0.71mm, P=0.001), delayed emergence of ovulatory follicles (17.0+/-0.32 vs 13.5+/-1.26, P=0.020), and reduced the interval from emergence to ovulation (7.0+/-0.32 vs 10.5+/-1.26d, P=0.020). We concluded that administration of EB altered ovarian follicular dynamics and tended to reduce plasma progesterone concentrations during treatment with an IVD that was used to resynchronize estrous cycles. However, use of a 7-d compared to an 8-day treatment with an IVD did not significantly affect follicle dynamics nor plasma progesterone concentrations during treatment.